Effect of Calcium Supplements on Imatinib Mesylate (Gleevec) Pharmacokinetics in Healthy Volunteers (CSTI571BUS 280) (UPCI 08-072).
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Calcium carbonate (Primary) ; Imatinib (Primary)
- Indications Cancer; Gastrointestinal disorders
- Focus Pharmacokinetics
- 13 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Apr 2011 Planned end date changed from 1 May 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 17 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.